4//SEC Filing
Lewis Michael 4
Accession 0000899243-19-003146
CIK 0001372299other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 4:26 PM ET
Size
12.1 KB
Accession
0000899243-19-003146
Insider Transaction Report
Form 4
HISTOGENICS CORPHSGX
Lewis Michael
Director
Transactions
- Exercise/Conversion
Common Stock
2019-02-08+403,845→ 4,014,415 total(indirect: See Footnote) - Exercise/Conversion
Common Stock
2019-02-08+1,244,444→ 5,258,859 total(indirect: See Footnote) - Exercise/Conversion
Common Stock Warrant (Right to Buy)
2019-02-08+403,845→ 0 total(indirect: See Footnote)Exercise: $0.01From: 2018-10-10Exp: 2023-10-10→ Common Stock (403,845 underlying) - Exercise/Conversion
Common Stock Warrant (Right to Buy)
2019-02-08+1,244,444→ 0 total(indirect: See Footnote)Exercise: $0.01From: 2016-11-22Exp: 2021-11-22→ Common Stock (1,244,444 underlying)
Footnotes (2)
- [F1]The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019.
- [F2]The reportable securities are owned by Wilmslow Estates Limited. The Reporting Person has no beneficial interest in the trust which ultimately owns the economic interest in Wilmslow Estates Limited, but other members of the Reporting Person's family are discretionary beneficiaries in such trust. To the extent the Reporting Person may be deemed to hold an indirect beneficial interest under applicable United States securities laws, the Reporting Person disclaims such beneficial interest. The Reporting Person disclaims beneficial ownership of these shares and this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Documents
Issuer
HISTOGENICS CORP
CIK 0001372299
Entity typeother
Related Parties
1- filerCIK 0001626134
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 4:26 PM ET
- Size
- 12.1 KB